HELLENIC CANNABIS GENETICS SA is establishing a medicinal & pharmaceutical cannabis production unit of Sativa L strains, using hydroponics cultivation according to GACP standards and cutting-edge processing technologies to transform the harvest into EU-GMP compliant medicinal & pharmaceutical products that follow the requirements of European Medicines Agency (EMA) as herbal medicines.
Our vision is to become the leading player in the European cannabis market in the field of research and development, working closely with healthcare academics and professionals.
Company Details
- Founded
- 2023
- Address
- 99 Tsimiski, 6th Floor / Office 26,greece
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://hecagen.com/
- HQ
- Thessaloniki, Central Macedonia
He.ca.gen. Sa Questions
He.Ca.Gen. Sa's website is https://hecagen.com/
He.Ca.Gen. Sa's LinkedIn profile is https://gr.linkedin.com/company/hecagen
He.Ca.Gen. Sa's industry is
Pharmaceutical Manufacturing
He.Ca.Gen. Sa's top competitors are
Curity Pharma,
Ia Agro,
Hellenic Pharma,
Argyropoulos & Co Shipping - Transport - Logistics,
Kb Life Pharmaceuticals Ltd,
Anthera Pharmaceuticals,
Endo Canna,
Apollon Crops,
Kalacan Hellas,
Phcann International.
He.Ca.Gen. Sa's categories are Pharmaceutical Manufacturing
He.Ca.Gen. Sa's founding year is 2023
